← Open Payments lookup

JODI FUEHRER: Open Payments

NPI 1982861589 · LINCOLN, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$22,283 in 88 payments from 14 companies in 2025. Trend: 2023 $929 · 2024 $1,271 · 2025 $22,283

Speaker / faculty: $18,925Travel & lodging: $1,853Food & beverage: $1,505
CompanyPaymentsAmount
Gilead Sciences, Inc.54$21,583
ABBVIE INC.10$165
Otsuka America Pharmaceutical, Inc.7$161
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$101
E.R. Squibb & Sons, L.L.C.4$59
Lundbeck LLC3$56
Noven Therapeutics, LLC2$34
Biogen, Inc.1$20
Janssen Pharmaceuticals, Inc1$20
Alkermes, Inc.1$19

Products named: Epclusa, REXULTI, VRAYLAR, Biktarvy, CAPLYTA, COBENFY, Xelstrym, MAVYRET.

Industry payments across NE — which companies pay providers there.